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T cell receptor (TCR) triggering by antigen results in metabolic reprogramming that, in turn, facilitates the exit of T cells
from quiescence. The increased nutrient requirements of activated lymphocytes are met, in part, by upregulation of cell
surface transporters and enhanced uptake of amino acids, fatty acids, and glucose from the environment. However, the
role of intracellular pathways of amino acid biosynthesis in T cell activation is relatively unexplored. Asparagine is a
nonessential amino acid that can be synthesized intracellularly through the glutamine-hydrolyzing enzyme asparagine
synthetase (ASNS). We set out to define the requirements for uptake of extracellular asparagine and ASNS activity in
CD8+ T cell activation. At early time points of activation in vitro, CD8+ T cells expressed little or no ASNS, and, as a
consequence, viability and TCR-stimulated growth, activation, and metabolic reprogramming were substantially impaired
under conditions of asparagine deprivation. At later time points (more than 24 hours of activation), TCR-induced mTOR-
dependent signals resulted in ASNS upregulation that endowed CD8+ T cells with the capacity to function independently
of extracellular asparagine. Thus, our data suggest that the coordinated upregulation of ASNS expression and uptake of
extracellular asparagine is involved in optimal T cell effector responses.
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Introduction
Naive T lymphocytes are small quiescent cells that take up low levels of  nutrients to sustain a basal catabolic 
metabolism. By contrast, antigenic stimulation of  T cells results in the upregulation of  nutrient receptors and 
the engagement of  anabolic processes to generate the biomolecules required for rapid growth, proliferation, 
and effector function. In recent years, critical roles in T cell activation and differentiation have been deter-
mined for upregulated expression of  the heterodimeric neutral amino acid transporter Slc7a5/Slc3a2 and 
glutamine (Gln) transporter Slc1a5 (1, 2). Furthermore, uptake of  a number of  amino acids, including Gln 
(2, 3), leucine (4, 5), tryptophan (6), and methionine (7), have been determined to play important functions 
in T cell activation. Despite the fact that a number of  key amino acids, such as Gln, serine, and alanine, can 
be synthesized intracellularly, extracellular sources of  these amino acids are required for T cells to meet their 
metabolic requirements upon exit from quiescence and to facilitate activation (8, 9).
The uptake and metabolism of amino acids play a key role in numerous intracellular processes in lym-
phocytes. For example, Gln is used as a building block for protein synthesis, to maintain activation of the 
mechanistic target of rapamycin complex 1 (mTORC1) (2), to replenish Krebs cycle intermediates via gluta-
minolysis (10), to synthesize glutathione (11), and to fuel posttranslational O-GlcNAcylation of key proteins 
(12). A further potential fate for Gln is the production of asparagine via the activity of the Gln-hydrolyzing 
enzyme asparagine synthetase (ASNS) (13). Interestingly, asparagine metabolism and uptake have emerged as 
a key target in cancer therapy. Thus, ASNS expression is a predictive biomarker in several human cancer types 
(14, 15) whereas asparaginases, that degrade extracellular asparagine, are a key chemotherapeutic drug for the 
treatment of leukemia and lymphomas that lack ASNS expression (13). Furthermore, upregulation of ASNS 
expression via the stress-induced activating transcription factor 4 (ATF4) occurs in B and T cells in response to 
glucose and amino acid deprivation (16, 17). However, to date, the physiological role of intracellular asparagine 
production via ASNS in T cell responses is unknown. Bacterial asparaginases act to suppress T cell activation 
(18, 19), implying that T cells require extracellular sources of asparagine. However, asparaginases frequently 
have glutaminase activity, and asparaginases that lack this function are less immunosuppressive in mice (20).
T cell receptor (TCR) triggering by antigen results in metabolic reprogramming that, in turn, facilitates 
the exit of T cells from quiescence. The increased nutrient requirements of activated lymphocytes are 
met, in part, by upregulation of cell surface transporters and enhanced uptake of amino acids, fatty 
acids, and glucose from the environment. However, the role of intracellular pathways of amino acid 
biosynthesis in T cell activation is relatively unexplored. Asparagine is a nonessential amino acid that 
can be synthesized intracellularly through the glutamine-hydrolyzing enzyme asparagine synthetase 
(ASNS). We set out to define the requirements for uptake of extracellular asparagine and ASNS 
activity in CD8+ T cell activation. At early time points of activation in vitro, CD8+ T cells expressed little 
or no ASNS, and, as a consequence, viability and TCR-stimulated growth, activation, and metabolic 
reprogramming were substantially impaired under conditions of asparagine deprivation. At later time 
points (more than 24 hours of activation), TCR-induced mTOR-dependent signals resulted in ASNS 
upregulation that endowed CD8+ T cells with the capacity to function independently of extracellular 
asparagine. Thus, our data suggest that the coordinated upregulation of ASNS expression and 
uptake of extracellular asparagine is involved in optimal T cell effector responses.
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In the current work, we set out to determine roles for extracellular asparagine uptake and intracellular 
asparagine production via ASNS in T cell activation. We show that, in naive mouse CD8+ T cells, ASNS 
expression is very low or absent, and asparagine uptake from the extracellular environment is required for 
maintenance of  cell viability, initial stages of  T cell growth, and activation in vitro. Furthermore, under con-
ditions of  asparagine deprivation, metabolic switching is compromised, likely as a consequence of  defec-
tive T cell activation, resulting in decrease nutrient uptake, reduced glycolytic flux, oxidative phosphoryla-
tion (OXPHOS), and ATP production. T cell receptor (TCR) triggering and metabolic reprogramming via 
mTORC1 and Myc activation are accompanied by increased expression of  ASNS, and subsequently CD8+ 
T cells can function independently of  extracellular sources of  asparagine. Using gene-trap mice expressing a 
hypomorphic Asns allele, we determined that ASNS expression is essential for in vitro CD8+ T cell activation 
in the absence of  extracellular asparagine. Together, these data suggest an important role for coordinated 
asparagine uptake and biosynthesis in T cell activation and effector responses.
Results
Asparagine uptake is required for initial cell growth, survival, and activation following TCR stimulation. We tested 
the effect of  asparagine and/or Gln deprivation on TCR-induced cell growth and activation. Naive TCR 
transgenic OT-I CD8+ T cells were stimulated for 24 hours with cognate peptide SIINFEKL in DMEM 
supplemented with or without asparagine and Gln. Deprivation of  either asparagine or Gln alone reduced, 
whereas the combined absence of  both amino acids substantially impaired, T cell viability (Figure 1A). Most 
(70%–80%) of  the T cells cultured in the presence of  both amino acids had initiated blastogenesis following 
24 hours of  TCR stimulation (Figure 1B). By contrast, OT-I T cells stimulated with peptide in the absence 
of  Gln or the combined absence of  Gln and asparagine did not form a blast cell population (Figure 1B). An 
intermediate phenotype was determined for OT-I cells activated in the absence of  asparagine alone; a reduced 
but reproducible proportion (20%–40%) of  the cells had a blast phenotype (Figure 1B). A fundamental role 
for amino acids is to act as building blocks for protein synthesis. Consistent with the effect on T cell growth, 
we determined that levels of  protein synthesis, as measured by assessment of  uptake and incorporation of  
O-propargyl-puromycin (OPP), by TCR-stimulated OT-I T cells were substantially reduced in the absence of  
extracellular asparagine and/or Gln (Figure 1, C and D).
Next, we assessed the effect of  amino acid deprivation on TCR-induced activation marker and cytokine 
expression. Antigen-stimulated OT-I T cell IL-2 secretion was inhibited 70%–90% by deprivation of  aspar-
agine and/or Gln (Figure 2A). Additionally, although TCR-induced upregulation of  the very early activa-
tion marker CD69 was unimpeded, cell surface expression of  CD25 and transferrin receptor CD71 was 
partially or completely inhibited by a lack of  extracellular asparagine and/or Gln (Figure 2B). Similarly, the 
proportions of  T cells expressing key transcription factors eomesodermin (Figure 2C) and T-box expressed 
in T cells (Tbet) (Figure 2D) were reduced under conditions of  asparagine or Gln deprivation. TCR-induced 
expression of  cytolytic effector protein granzyme B was low under all media conditions after 24 hours of  
stimulation. Asparagine deprivation impaired TCR-induced granzyme B upregulation, as assessed following 
48 hours of  stimulation (Figure 2E). Both proportions of  positive cells (Figure 2F) and levels of  granzyme B 
within positive cells, as assessed by mean fluorescence intensity (Figure 2G), were reduced compared with 
control conditions. As compared with either asparagine deprivation or control conditions, Gln deprivation 
more severely impaired TCR-induced granzyme B expression (Figure 2, E–G).
A key question was whether the absence of  extracellular asparagine impinged on the expression of  T 
cell activation markers and effector proteins was simply a consequence of  decreased protein synthesis or 
also affected gene transcription. To this end, we assessed transcript levels of  Il2 and Tbx21 (encoding Tbet) 
following activation of  OT-I T cells in the presence or absence of  asparagine for 6 and 24 hours, respec-
tively, by quantitative reverse transcriptase-PCR (qRT-PCR). Data indicated that early upregulation of  Il2 
expression was unimpaired in the absence of  asparagine (Figure 2H), indicating that decreased IL-2 secre-
tion was a consequence of  posttranscriptional effects, most likely decreased protein synthesis. By contrast, 
Tbx21 levels were much reduced under conditions of  asparagine deprivation (Figure 2I), indicating that 
decreased transcript levels contribute to the effects on Tbet expression.
IL-2 is a potent T cell growth factor and mitogen. Thus, it was possible that a failure to produce IL-2 was 
responsible for reduced OT-I T cell viability, growth, and activation under conditions of  amino acid depri-
vation. However, addition of  exogenous recombinant IL-2 did not rescue T cell viability, protein synthesis, 
or enhance TCR-induced expression of  granzyme B in asparagine- or Gln-deprived media (Supplemental 
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Figure 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight. 
137761DS1). Taken together, these data indicate that CD8+ T cells require extracellular sources of  asparagine 
and Gln to maintain cell viability and initiate cell growth, protein synthesis, and activation following TCR 
stimulation. Either amino acid alone is sufficient to maintain a reduced proportion of  viable cells; however, 
the combined absence of  asparagine and Gln results in catastrophic levels of  cell death.
Asparagine availability regulates TCR-induced metabolic reprogramming. Nutrient uptake and metabolic repro-
gramming following TCR stimulation are highly coordinated. Therefore, it was of interest to determine wheth-
er the availability of asparagine impinged upon T cell metabolism. The tryptophan metabolite kynurenine is 
transported into T cells via the neutral amino acid transporter Slc7a5 (also known as CD98) (21), which also 
serves as a transporter for essential amino acids tryptophan, leucine, phenylalanine, and methionine. We took 
advantage of the fluorescent properties of kynurenine as well as the glucose analog 2-NB-d-glucose (2-NBDG) 
and long-chain fatty acid analog 4, 4-difluoro-5, 7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-hexadecanoic 
acid (BODIPY) C16 to assess the effect of amino acid deprivation on TCR-induced nutrient uptake. FACS 
analysis demonstrated that OT-I T cells activated for 24 hours in the absence of asparagine and/or Gln had 
reduced capacity to uptake glucose (Figure 3A), kynurenine (Figure 3B), and BODIPY C16 (Figure 3C) as 
compared with cells activated in the presence of both amino acids. Reduced TCR-induced nutrient uptake 
was associated with impaired cell surface expression of nutrient transporters GLUT1 (also known as Slc2a1), 
CD98, and CD36 under conditions of asparagine with or without Gln deprivation (Figure 3, D–F).
Analysis of  extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) serve as proxy 
measures for lactate secretion/glycolytic rate and OXPHOS, respectively. Seahorse metabolic analysis 
demonstrated that OT-I T cells activated under conditions of  asparagine deprivation had reduced basal 
ECAR (Figure 3G) and OCR (Figure 3H). To assess mitochondrial function in more detail, we performed 
a Mitostress test. Data indicated that cells activated in the absence of  asparagine had substantially reduced 
basal and stressed OCR (Supplemental Figure 2A). Despite reduced OCR of  asparagine-deprived T cells, 
their basal OCR/ECAR ratio was consistently higher than cells activated in asparagine-replete media (Sup-
plemental Figure 2B), consistent with a failure to effectively engage glycolytic pathways and suggestive of  
overall reduced levels of  cellular metabolism. Consistent with these data, levels of  OT-I T cell ATP produc-
tion were reduced by 50%–75% in asparagine- and/or Gln-deprived media (Figure 3I).
The availability of  amino acids, including Gln, has previously been shown to play a central role in T 
cell activation and metabolism through regulation of  the activity of  the mTORC1 kinase complex (1, 2). 
Analysis of  phosphorylation of  the downstream substrate ribosomal protein S6 (22) determined that, in the 
absence of  extracellular asparagine, TCR-induced mTORC1 activation was impaired but not blocked (Fig-
ure 3J). Taken together, these data indicate that, at initial stages of  T cell activation, the bioavailability of  
asparagine is essential for T cell activation and subsequently determines the extent of  TCR-induced nutri-
ent uptake, glycolytic flux, OXPHOS, and energy production, with a partial effect on mTORC1 activation.
Figure 1. Extracellular asparagine is required to maintain viability and initiate cell growth following T cell receptor stimulation. OT-1 T cell receptor (TCR) 
transgenic T cells were stimulated with cognate SIINFEKL peptide for 24 hours in DMEM supplemented with or without asparagine and Gln, as indicated. (A) 
T cell viability was assessed by exclusion of Live/Dead Aqua dyes and FACS. (B) T cell growth was assessed by analysis of forward scatter and side scatter area 
(FSC-A/SSC-A) parameters on gated live cells by flow cytometry. (C) Nascent protein synthesis was assessed by incorporation of OPP, intracellular staining, 
and labeling using Click chemistry reagents and FACS analysis. Cycloheximide (CHX) was used as a negative control. (D) O-propargyl-puromycin (OPP) mean 
fluorescence intensity (MFI) was assessed by FACS analysis. Data are from 1 of 3 experiments, and individual data points (n = 3) represent technical replicates. 
*P < 0.05, ****P < 0.0001, as assessed by 1-way ANOVA, with Tukey’s multiple comparisons test. 
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CD8+ T cells lose requirement for extracellular asparagine upon prolonged TCR stimulation. Notably, at early time 
points (24 hours), in contrast to Gln deprivation, a reduced but consistent proportion of  OT-I T cells stimu-
lated in the absence of  extracellular asparagine demonstrated activation profiles comparable to cells stimu-
lated under control conditions (i.e., blast phenotype, elevated activation marker expression/OPP incorpora-
tion, and phospho-S6+) (Figures 1–3). We sought to determine whether T cell activation remained dependent 
on extracellular asparagine at later time points. Following 72 hours of  peptide stimulation, levels of  OT-I 
cell viability were comparable in asparagine-deprived conditions as compared with control media conditions 
(Figure 4A). By contrast, OT-I T cell viability was much impaired under conditions of  Gln deprivation 
(10%–20%), whereas T cells did not survive prolonged culture in the combined absence of  both amino acids 
(Figure 4A). Viable T cells activated for 72 hours under control conditions and in the absence of  asparagine, 
but not Gln, were uniformly large blasting cells, as determined by analysis of  forward scatter/side scatter 
parameters (Figure 4B). Furthermore, analysis of  CellTrace Violet dilution after 72 hours of  activation indi-
cated that asparagine deprivation reduced but did not block antigen-stimulated T cell proliferation (Figure 4, 
C and D). By contrast, Gln deprivation completely prevented T cell proliferation in vitro.
Comparison of OT-I T cell phenotypes after 72 hours of peptide stimulation indicated that levels of CD25, 
CD71, and granzyme B expression were equivalent in control cells and cells activated in asparagine-deprived 
Figure 2. Extracellular asparagine is limiting for initial TCR-induced T cell activation. OT-1 TCR transgenic T cells were stimulated with cognate SIINFEKL 
peptide for 6 (H), 24 (A–D, and I), or 48 hours (E–G) in DMEM supplemented with or without asparagine and/or Gln, as indicated. (A) Levels of IL-2 in culture 
supernatants were assessed by ELISA. (B) Histograms show levels of cell surface activation marker expression on live-gated cells. Data are representative 
of 1 of at least 3 repeated experiments. Proportions of live-gated cells expressing transcriptions factors eomesodermin (eomes) (C) and Tbet (D) were deter-
mined by intracellular staining and FACS. (E) Representative histograms show levels of intracellular granzyme B in live-gated cells. Proportions of granzyme 
B+ (GZMB+) cells (F) were determined. Relative levels of expression of GZMB in live GZMB+ cells were assessed as mean fluorescence intensity (MFI) (G). 
Levels of Il2 (H) and Tbx21 (I) transcripts were determined by qRT-PCR. Levels are fold change using the ddCT method and Rpl13a as a housekeeping gene. 
For H and I, dots represent biological replicates (n = 4) from 1 of 2 repeated experiments. For all other data, dots represent technical replicates (n = 3) from at 
least 3 repeated experiments. *P < 0.05, **P < 0.01, ****P < 0.0001, as assessed by 1-way ANOVA, with Tukey’s multiple comparisons test.
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conditions (Figure 4, E–H). By contrast, T cells stimulated in the absence of Gln had very low levels or absent 
expression of cell surface activation markers and granzyme B (Figure 4, E–H). Furthermore, and in contrast to 
results from earlier time points, OT-I T cells activated for 72 hours in the absence of asparagine had unimpaired 
capacity to uptake glucose and long-chain fatty acids (Supplemental Figure 3, A and B), whereas levels of ATP 
production were comparable to control levels (Supplemental Figure 3C).
Furthermore, we tested the effects of  initial T cell activation in the presence of  extracellular asparag-
ine and Gln followed by switching to media lacking asparagine and/or Gln. OT-I T cells were activated in 
IMDM for 24 hours, then switched to DMEM with or without asparagine and Gln for an additional 24 hours. 
Under all conditions, viable T cells had a blasting phenotype and expressed similar levels of  CD71. Nonethe-
less, T cells transferred to Gln-free media had reduced viability and modestly reduced cell size and demon-
strated impaired uptake of  2-NBDG (Supplemental Figure 3, D–H). By contrast, T cells transferred to aspar-
agine-free media after initial activation in asparagine-replete conditions were unimpaired in these parameters.
We assessed the functional capacity of  effector cytotoxic T lymphocytes (CTLs) differentiated for 6 days 
in the absence of  either asparagine or Gln. OT-I T cells differentiated in the absence of  Gln did not produce 
IFN-γ, and reduced proportions of  cells were competent to produce TNF upon antigenic restimulation in 
nutrient-replete media (Figure 4, I and J). By contrast, CTLs differentiated in the absence of  asparagine pro-
duced equivalent levels of  effector cytokines upon restimulation in nutrient-replete media as compared with 
control cells (Figure 4, I and J). These data indicate that extracellular Gln but not asparagine is essential for 
CD8+ T cell differentiation to an inflammatory phenotype. We next sought to test whether there was any 
requirement for extracellular sources of  asparagine in effector T cell function. To this end, we differentiated 
OT-I T cells in nutrient-replete IMDM media for 5 days, transferred to DMEM with or without asparagine 
prior to restimulation of  the resultant CTLs in the presence or absence of  asparagine. Asparagine deprivation 
did not impede effector T cell secretion of  IFN-γ (Figure 4K).
Figure 3. Extracellular asparagine is limiting for initial TCR-induced metabolic reprogramming. OT-1 T cells were stimulated with cognate SIINFEKL peptide for 24 
hours in DMEM supplemented with or without asparagine and/or Gln, as indicated. Uptake of fluorescent glucose analogue 2-NBDG (A), kynurenine (B), and long-
chain fatty acid BODIPY-C16 (C), and cell surface expression of transporters GLUT1 (D), CD98 (E), and CD36 (F) were assessed by FACS analysis. Data are mean fluo-
rescence intensity values (MFI) or percentage of cells positive, as indicated. (G and H). Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of 
activated OT-1 T cells were assessed using a Seahorse metabolic analyzer. (I) ATP production was assessed using a luminescence-based assay and luminometer. (J) 
Proportions of phospho-ribosomal protein S6+ (pS6 S240/244+) cells were assessed by intracellular staining and FACS analysis. Data are representative of 2 (G and 
H) or 3 repeated experiments. Data points represent technical replicates; (A–F, and J) n = 3, (G and H) n = 30, and (I) n = 4. *P < 0.05, **P < 0.01, ***P < 0.001, ****P 
< 0.0001, as determined by 1-way ANOVA, with Tukey’s multiple comparisons test (A–F, and I), 2-tailed Student’s t test (G and H), or 2-way ANOVA (J).
6
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(9):e137761  https://doi.org/10.1172/jci.insight.137761
CD8+ T cells upregulate ASNS expression via the mTOR signaling pathway. We reasoned that the initial depen-
dence of CD8+ T cells on extracellular asparagine could be a consequence of low/absent ASNS expression and 
that ASNS might be upregulated following T cell activation. To test this, OT-I T cells were activated for various 
time periods in nutrient-replete conditions and Western blot analysis of ASNS expression was performed. 
These data indicated that ASNS was not expressed in naive OT-I cells and at very low levels in thymocytes 
but was upregulated in response to TCR stimulation (Figure 5A and Supplemental Figure 4). Activation of the 
mTOR pathway and Myc transcription factor is central to metabolic reprogramming following T cell activation 
(23), whereas our data suggested that asparagine availability was rate limiting for mTOR activation at early 
stages of T cell activation (Figure 3). Western blots showed that treatment with rapamycin and Myc inhibitors 
substantially reduce TCR-induced upregulation of ASNS (Figure 5A and Supplemental Figure 4), suggesting 
that ASNS upregulation is a feature of mTORC1-dependent T cell metabolic reprogramming.
T cell development and homeostasis are unimpaired in ASNS gene-trap mice. To determine the role of  ASNS 
expression in T cells, we assessed AsnsTm1a mice, a genetically modified mouse strain with a gene-trap inser-
tion in intron 2 of  the Asns locus. Previous studies of  the role of  ASNS in neural development determined 
that the gene-trap approach resulted in a hypomorphic Asns allele (24). Western blotting analysis of  activat-
ed lymph node T cell lysates determined that homozygous expression of  the hypomorphic allele resulted in 
Figure 4. T cells lose requirement for extracellular asparagine upon prolonged activation. OT-1 T cells were stimulated with cognate SIINFEKL peptide for 72 
hours (A–G) or were differentiated for 6 days (H and I) in DMEM supplemented with or without asparagine and/or Gln or complete IMDM (J and K), as indicated. 
T cell viability (A) and proportions of blasting cell populations (B) were assessed by exclusion of Live/Dead Aqua dyes and analysis of forward scatter and side scat-
ter area (FSC-A/SSC-A) parameters by flow cytometry, respectively. For analysis of TCR-induced proliferation, cells were labeled with Cell Trace Violet (CTV) prior 
to stimulation. Histograms are representative of data from 2 repeated experiments (C). Division indices were calculated using FlowJo software (D). Proportions 
of live-gated T cells expressing CD25 (E), CD71 (F), or granzyme B (G and H) were determined by flow cytometry. (I and J) Effector cytotoxic T lymphocytes (CTLs) 
were differentiated for 6 days in DMEM with or without asparagine/Gln, then restimulated in complete IMDM for 4 hours. Proportion of IFN-γ+ and TNF+ cells were 
determined by intracellular staining and FACS analysis. (K) Effector CTLS were differentiated in complete IMDM for 5 days, before a 24-hour washout in DMEM 
with or without asparagine, then were restimulated in DMEM with or without asparagine for 24 hours. IFN-γ levels in supernatants were determined by ELISA. 
Data are representative of 2 (C and D) or 3 repeated experiments. In all graphs, individual data points represent technical replicates (n = 3). **P < 0.01, ****P < 
0.0001, as determined by 1-way ANOVA with Tukey’s multiple comparisons test (A, B, D–F, and H) or 2-way ANOVA with Sidak’s multiple comparisons test (I–K).
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a more than 90% decrease in ASNS protein expression, as compared with WT littermate controls, whereas 
heterozygous cells expressed intermediate levels (Figure 5B and Supplemental Figure 4). For all genotypes, 
TCR-induced ASNS expression was abolished by rapamycin (Figure 5B), consistent with the results from 
OT-I TCR transgenic experiments (Figure 5A). We next sought to determine whether ASNS deficiency 
impacted T cell developmental processes. Flow cytometry analysis of  thymus and lymph node cells deter-
mined that homozygous AsnsTm1a mice had similar proportions and numbers of  thymocyte populations and 
mature CD4+ and CD8+ T cells as compared with WT and heterozygous controls (Supplemental Figure 5, 
A–C). Furthermore, proportions of  naive (CD44loCD62Lhi), central memory (CD44hiCD62Lhi), and effec-
tor/effector memory (CD44hiCD62Llo) phenotype CD4+ and CD8+ T cells were similar in AsnsTm1a and con-
trol mice (Supplemental Figure 5D). These data indicate that homozygous expression of  the hypomorphic 
Figure 5. Asparagine synthetase expression enables T cell responses in asparagine-depleted conditions. (A) Western blots show asparagine synthetase 
(ASNS) protein levels in lysates of OT-1 T cells stimulated in IMDM with SIINFEKL peptide with or without rapamycin (rap) or Myc inhibitor (Myci) for the indi-
cated time periods, or thymocytes. (B) ASNS levels in lysates from activated lymph node T cell from homozygous, heterozygous, or WT AsnsTm1a mice. (A and 
B) β-Actin serves as a protein loading control. Values underneath blots represent relative ASNS expression levels (A) or ASNS levels as percentage of WT (B) 
calculated using the LI-COR Odyssey imaging system from 1 of 2 repeated experiments. Lymph node T cells from AsnsTm1a mice and controls were stimulated 
with anti-CD3/28 antibodies for 48 hours in DMEM with or without asparagine or Gln. Cell viability was assessed by exclusion of Live-Dead Aqua dye and flow 
cytometry (C). Proportions of gated live CD8+ T cells undergoing blastogenesis were assessed by FACS analysis of FSC-A/SSC-A parameters (D and E). Control 
cells were cultured in the presence of IL-7, which maintains cell viability without inducing T cell activation (E). Gated live CD8+ T cells were analyzed by FACS 
for levels of intracellular granzyme B (F) and cell surface CD71 (G). (H) Purified control and AsnsTm1a CD8+ T cells were activated in asparagine-free DMEM for 6 
days. Live cells were enumerated throughout the time course of the experiment. (C–H) Data represent 1 of at least 3 repeated experiments, and individual dots 
represent technical replicates (n = 3). *P < 0.05, **P < 0.01, ****P < 0.0001, as determined by 2-way ANOVA with Sidak’s multiple comparisons tests. 
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Asns allele does not impinge on T cell development in the thymus nor on peripheral T cell homeostasis in a 
specific-pathogen free animal facility.
ASNS expression is required for CD8+ T cell activation in the absence of  extracellular asparagine. To test the role for 
ASNS in T cell activation, we stimulated polyclonal lymph node cells from AsnsTm1a and control mice for 48 hours 
with plate-bound CD3/CD28 antibodies in DMEM media supplemented with or without Gln and/or asparag-
ine. Similar to results using OT-I T cells, FACS analysis of polyclonal CD8+ T cells demonstrated impaired T cell 
viability in asparagine- and Gln-deprived conditions (Figure 5C). ASNS-deficient T cells had lower cell viability 
under conditions of asparagine deprivation than control T cells (Figure 5C). Similarly, TCR-induced CD8+ T 
cell blastogenesis was completely abrogated by the combination of genetic ASNS deficiency and extracellu-
lar asparagine deprivation (Figure 5, D and E). The combined absence of extracellular asparagine and ASNS 
deficiency also prevented TCR-induced upregulation of activation marker CD71 and granzyme B (Figure 5, 
F and G). Moreover, we assessed population expansion and survival of control and AsnsTm1a CD8+ T cells in 
asparagine-free media following 2 days of CD3/28 stimulation followed by a further 4 days of IL-2 stimulation. 
Although both control and AsnsTm1a cell numbers were reduced during the first 2 days of activation in asparag-
ine-free conditions, viable control T cell numbers recovered during days 2–6 (Figure 5H), coincident with ASNS 
upregulation. By contrast, numbers of viable AsnsTm1a T cells were markedly impaired (Figure 5H). Taken togeth-
er, these data suggest that T cell activation, metabolic reprogramming, and mTOR-dependent ASNS upregula-
tion enable CD8+ T cells to function independently of extracellular sources of asparagine.
Discussion
T cell activation is accompanied by, and dependent on, metabolic reprogramming and substantial upregulation 
of nutrient uptake. In the current work, we determined that, initially, antigen-stimulated CD8+ T cells require 
extracellular sources of the nonessential amino acid asparagine to maintain viability, to grow, and to initiate 
activation and metabolic remodeling. However, upon prolonged stimulation, CD8+ T cells diverge from a strict 
asparagine-dependent phenotype as a consequence of upregulation of ASNS expression. By contrast, Gln 
remains an essential amino acid for T cells throughout all stages of activation and differentiation.
The availability of nutrients is key to immune functionality. Gln is the most abundant amino acid in 
human serum, whereas the results of the current work confirm the findings of previous studies that Gln trans-
porter and Gln uptake expression is critical for T cell activation (2). It had been assumed that lymphocytes are 
auxotrophic for asparagine through the interpretation of studies of the effect of bacterial asparaginases on 
transformed and nontransformed lymphocyte populations (13, 18, 19). Our results confirm that extracellular 
asparagine is required for initial stages of CD8+ T cell activation. In the absence of asparagine or Gln alone, 
TCR stimulation results in substantial levels of T cell death. Nonetheless, our data indicate that asparagine can 
partially compensate for the absence of Gln, and vice versa, as in the combined absence of both amino acids, 
TCR-stimulated T cells fail to survive. Similar results have been reported for transformed cells; in the absence 
of Gln, asparagine is required to maintain viability and proliferation of cancer cells, whereas high ASNS is 
associated with poor prognosis in several cancer types (25, 26).
Defective CD8+ T cell activation, growth, and metabolic reprogramming in asparagine-deprived condi-
tions in vitro was associated with, and likely to be a consequence of, a reduced capacity for protein synthesis. 
Asparagine deprivation results in translational pausing at asparagine codons and decreased protein synthesis 
with a dominant effect on asparagine-rich proteins (27). In breast cancer cells, asparagine availability influenc-
es expression of  proteins that regulate epithelial-mesenchymal transition, with subsequent effects on metas-
tasis (14). Whether reduced asparagine availability effects specific subsets of  proteins or has a more global 
effect on the T cell proteome remains to be investigated. Asparagine deprivation also resulted in decreased 
TCR-induced mRNA levels of  the transcription factor Tbx21 but not Il2. Therefore, asparagine deprivation 
can effect expression of  proteins either through posttranscriptional effects alone or a combination of  reduced 
transcription and protein synthesis. We anticipate that the major effect of  asparagine deprivation on T cell 
activation is to limit protein synthesis but that there may also be indirect effects on transcription, perhaps as a 
consequence of  diminished protein expression of  the transcriptional machinery. An intriguing additional pos-
sibility is that asparagine availability regulates T cell activation by regulating the activity of  the TCR proximal 
kinase Lck and subsequent downstream signals (28).
In addition to its fundamental role in protein synthesis, asparagine has been reported to function as an 
exchange factor for additional amino acids in tumor cells (29). Thus, intracellular asparagine levels control 
uptake of serine, arginine, and histidine and thereby controls mTORC1 activation and protein synthesis. Our 
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experiments indicated that the availability of asparagine regulated TCR-induced mTORC1 activation, suggest-
ing that asparagine may have a similar role as an amino acid exchange factor in T cells. An additional nonex-
clusive possibility is that asparagine deprivation may indirectly influence mTORC1 activation as a consequence 
of reduced expression of nutrient transporters and uptake of amino acids such as leucine. Consistent with this 
hypothesis, our data indicated that asparagine deprivation resulted in reduced TCR-induced expression of  
CD98 and capacity for uptake of kynurenine.
Our data have determined that effector CD8+ T cell populations have the capacity to function independently 
of extracellular asparagine, as a consequence of ASNS expression. These results also emphasize an additional 
role for Gln in T cell activation; in the absence of asparagine, Gln is required to serve as a nitrogen donor for the 
synthesis of asparagine via ASNS activity (13). Our analyses of Asns gene-trap mice strongly suggest that T cell 
development does not require ASNS expression. However, it is possible that residual expression of low levels of  
ASNS in AsnsTm1a mice, quantified as less than 10% of WT levels, is sufficient to enable T cell development or 
that extracellular asparagine levels in the thymus are sufficient for ASNS expression to be redundant. Indeed, the 
bioavailability of asparagine varies between distinct anatomical locations in vivo (14). Therefore, there are likely 
to be varying context-dependent requirements for ASNS expression on T cell development, homeostasis, and 
inflammatory responses in vivo. Wu and colleagues recently reported that, in mice fed an asparagine-free diet, 
T cell homeostasis was largely unimpaired while CD8+ T cell responses to Listeria monocytogenes infection and 
B16 melanoma were impeded, as compared with mice receiving asparagine (28). Those data are consistent with 
an important role for asparagine uptake in T cell activation in vivo and with previous reports of the immuno-
suppressive effects of asparaginases (19), with the caveat that asparaginases frequently have glutaminase activity. 
Nonetheless, it is unclear at present when and where extracellular asparagine is limiting under physiological con-
ditions and what role ASNS upregulation plays in CD8+ T cell activation in vivo. Similarly, the role for ASNS 
and asparagine uptake in CD4+ T cell activation and differentiation, as well as in other immune cell populations, 
remains to be explored. Future analysis of the impact of lineage-specific deletion of ASNS in the T cell lineage 
and in vivo analyses of ASNS-deficient T cell function will resolve this outstanding question. Nonetheless, our 
data show that the low levels of ASNS expression in peripheral AsnsTm1a CD8+ T cells are insufficient to maintain 
TCR-induced activation in the complete absence of extracellular asparagine in vitro.
It is important to note that ASNS activity generates both glutamate (Glu) and asparagine, and depletes 
Gln and aspartate. The extent to which intracellular Glu levels are affected by ASNS deficiency is not clear. 
In this regard, Glu is taken up from the extracellular environment by activated T cells, and intracellular levels 
of both Gln and Glu increase substantially in T cells activated in nutrient-replete conditions (8). Nonetheless, 
our experiments suggested that AsnsTm1a T cell responses were not impaired when extracellular asparagine was 
available, suggesting that the effect of ASNS deficiency on T cell activation was unlikely to be a consequence of  
reduced Glu levels. It should be noted that these experiments depended on the use of DMEM medium, which 
is relatively low in glucose (4 mM) and was supplemented with dialyzed serum, to control Gln and asparagine 
levels. Under such conditions, control T cell responses were suboptimal, therefore, it remains possible that ASNS 
expression is rate limiting for optimal T cell responses in nutrient-replete conditions.
In summary, our work has shown that activated T cells coordinate nutrient uptake with upregulated expres-
sion of key regulators of intracellular amino acid biosynthesis. Elevated ASNS expression via the mTORC1 
and Myc pathways is part of a transcriptional program that endows T cells with the capacity to maximize their 
nutrient resources during effector immune responses.
Methods
Mice. AsnsTm1a(EUCOMM)/Wtsi (referred to herein as AsnsTm1a) gene-trap mice were generated by the International 
Mouse Phenotyping Consortium and were imported to the University of Leeds St. James’s Biomedical Ser-
vices (SBS) animal facility from MRC Harwell (Harwell, United Kingdom). AsnsTm1a mice were backcrossed 
with in-house C57BL/6J mice; in all experiments, littermates and/or age-matched in-house bred C57BL/6J 
mice were used as controls. OT-I Rag1–/– (30) mice were maintained in the SBS facility. Where applicable, 
group sizes are indicated by individual data points.
Cell culture and stimulation. OT-I TCR transgenic or polyclonal T cells were obtained from lymph nodes and/
or spleens of OT-1 Rag1–/– or AsnsTm1a and control mice, respectively. For experiments investigating the role of  
extracellular amino acids, cells were cultured in DMEM containing 4 mM glucose (Gibco) supplemented with 
5% dialyzed FBS (Gibco), penicillin-streptomycin (Gibco), 50 μM 2-mercaptoethanol (Gibco) with or with-
out 2 mM L-Gln and 300 μM anhydrous L-asparagine (both Sigma-Aldrich). Otherwise, cells were cultured 
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in IMDM (Gibco) containing 25 mM glucose, 5% FBS, 50 μM 2-mercaptoethanol, 4 mM L-Gln, and 190 μM 
freebase L-asparagine. OT-I T cells were stimulated with 10-8 M SIINFEKL peptides. For generation of OT-I 
CTLs, after 2 days of culture, cells were washed and cultured for a further 4 days in media containing 20 ng/mL 
recombinant human IL-2 (Peprotech). For analysis of effector cytokine production, T cells were restimulated in 
media containing 10-9 M SIINFEKL and Brefeldin A (2.5 μg/mL, Sigma-Aldrich). For activation of polyclonal 
T cells, mixed LN cells were activated using plate-bound anti-CD3ε (1.5 μg/mL) (2C11, BioLegend) and soluble 
anti-CD28 (37.51, BioLegend, 1 μg/mL) as indicated, for2 days, then transferred to media containing 20 ng/
mL IL-2. In some experiments, CD8+ T cells were purified by negative selection and magnetic sorting (Miltenyi 
Biotech) prior to activation as previously described. To assess the role of the mTORC1 and Myc pathways in 
regulating ASNS expression, cells were stimulated in the presence or absence of 100 nM rapamycin (Tocris Bio-
science) or Myc inhibitor 10058-F4 (Sigma-Aldrich).
Flow cytometry and antibodies. The following antibodies were used: CD4-allophycocyanin (APC) or -brilliant 
violet 421 (BV421) (clone GK1.5), CD8β-phycoerythrin-Cy7 (clone YTS156.7.7), CD25-PE (clone PC61.5), 
CD36-PE (clone HM36), CD44-APC-Cy7 (clone 1M7), CD69-peridinin-chlorophyll-protein Cy5.5 (PerCP 
Cy5.5) (clone H1.2F3), CD71-FITC (clone RI7217), CD98-Alexa Fluor 647 (clone 4F2), TCRαβ-FITC (clone 
H57-597), IFN-γ–AF488 (clone XMG1.2), TNF-PerCP Cy5.5 (clone MP6-XT22), granzyme B–Pacific blue 
(clone GB11), and Tbet-PE (clone 4B10) (all BioLegend) and eomesodermin-AF488 (eBioscience). Unconju-
gated anti-rpS6 phospho-Ser240/244 (clone D68F8, Cell Signaling Technology) was counterstained with goat 
anti-rabbit secondary reagents (Molecular Probes). Live/dead aqua and Zombie NIR dyes were from Life 
Technologies and BioLegend, respectively. For intracellular staining, cells were fixed in Phosflow fix buffer (BD 
Pharmingen) or eBioscience FoxP3 fix/permeabilization buffers prior to staining in permeabilization buffers. 
For analysis of protein synthesis, cells were labeled with OPP (20 μM, Stratech Scientific) and the Click-iT Plus 
AF488 picolyl azide kit (Life Technologies) according to the manufacturers’ instructions. Cycloheximide (100 
μg/mL, Sigma-Aldrich) was added 15 minutes prior to labeling as a negative control. For analysis of nutrient 
uptake, T cells were cultured with 2-deoxy-2-([7-nitro-2, 1, 3-benzoxadiazol-4-yl]amino)-glucose (2-NBDG) (50 
μM for 1 hour, Abcam), BODIPY-C16, 1 μM, for 30 minutes, Invitrogen) or kynurenine (800 μM in HBSS buf-
fer for 4 minutes, Sigma-Aldrich), and washed 3 times in PBS. For BODIPY and kynurenine uptake, cells were 
counterstained with Zombie NIR prior to FACS analysis. Samples were acquired with LSR II (BD) or Cytoflex 
LX (Beckman Coulter) flow cytometers, and data were analyzed using FlowJo software (Treestar).
ELISA. To prevent consumption of secreted IL-2, CD25 blocking antibodies (clone 3C7, BioLegend) were 
added to culture media prior to T cell stimulation. Cytokine levels in culture supernatants were assessed using 
mouse IL-2 and IFN-γ DuoSet ELISA kits (R&D Systems), according to the manufacturers’ instructions.
Quantitative RT-PCR. OT-I T cells were activated in DMEM with or without asparagine as described, and 
cell pellets (1.5–2 × 106) stored at –80°C until RNA preparation. RNA was prepared using Qiagen RNeasy Mini 
Kits and cDNA synthesized using Superscript III RT and oligo(dT)20 primers (Life Technologies). The relative 
expression of Rpl13a was used to normalize gene expression across samples. Il2 and Tbx21 expression was quan-
tified by qRT-PCR using the ddCt method and Taqman reagents (Taqman Universal Mastermix II, Applied 
Biosystems) using the QuantStudio 7 Real-Time PCR system (Applied Biosystems). The following Taqman 
probes were used: Il2 — Mm00434256_m1; Tbx21 — Mm00450960_m1; Rpl13a — Mm05910660_g1. Samples 
were amplified using a 2-step cycling method (40 cycles: 95°C for 15 seconds, 60°C for 1 minute).
Metabolic analyses. ECAR and OCR values were acquired using a Seahorse XFe96 Analyzer, as described 
previously (31). Briefly, stimulated T cells were plated (105 viable cells/well) in Cell-Tak (Corning) coated 
Seahorse Analyzer XFe96 culture plates in Seahorse assay media supplemented with glucose (10 mM), Gln 
(2 mM), and pyruvate (1 mM). Data were collected in Wave software and analyzed using GraphPad Prism 
software. For Mito Stress tests, oligomycin (1 μM), FCCP (1.5 μM), and rotenone/antimycin A (0.5 μM) were 
injected using the standard XFe96 protocol.
ATP assay. T cells were stimulated as indicated in figure legends. For the measurement of cellular ATP lev-
els, a luminescence-based kit (Luminescent ATP Detection Assay Kit, Abcam, ab113849) was used according 
to the manufacturer’s instructions.
Western blotting. T cells were stimulated as indicated in figure legends, and cell lysates prepared in RIPA 
buffer. Protein concentration of lysates was assessed by Bradford Assay (Thermo Fisher Scientific), and 20 μg 
protein per sample loaded on polyacrylamide gels. Samples were separated by SDS-PAGE, and proteins trans-
ferred to nitrocellulose membranes (Bio-Rad). Membranes were blocked in LI-COR blocking buffer (LI-COR 
Biosciences). Primary antibodies (rabbit anti-ASNS – HPA029318, Atlas Antibodies, mouse anti–β-actin, clone 
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AC-15, Sigma-Aldrich) were diluted in LI-COR blocking buffer and detected using goat anti-rabbit-AF680 and 
goat anti-mouse AF790 secondary reagents (Molecular Probes). Protein bands were detected and quantified 
using a Li-COR Odyssey Imaging System.
Statistics. Two-tailed Student’s t tests, Mann-Whitney test, and 1- or 2-way ANOVA with Tukey’s or Sidak’s 
multiple comparison tests were performed using GraphPad Prism software. P values or adjusted P values of less 
than 0.05 were considered significant. In graphs, dots represent values from replicate samples, and error bars 
represent SDs. Numbers of experimental and/or technical replicates are described in figure legends.
Study approval. All mouse breeding and experiments were approved by and subject to the conditions of a UK 
Home Office Project License (PDAD2D507) held by RJS and were reviewed by the University of Leeds Animal 
Welfare and Ethics Board.
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